VLCGX Performance — Large Cap Core Fund
Data updated: 2026-08-14
VLCGX returned +8.70% year to date and +20.29% over one year to May 2026. Annualised returns are +16.30% over 3 years and +9.77% over 5 years. The fund trailed its US Large Blend category average: $100 invested three years ago grew to $157, against $165 for the category, and to $120 over one year, against $122. Volatility over the past three years was 13.63% a year. In the 12 months to May 2026 the fund took in a net $174.6M, and assets reached $819.17M.
VLCGX Growth of $100
What $100 invested in Large Cap Core Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | VLCGX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $120 | $122 |
| 3 years (Jun 2023 – May 2026) | $157 | $165 |
| 5 years (Jun 2021 – May 2026) | $159 | $164 |
| Since data start (Sep 2019 – May 2026) | $237 | $229 |
VLCGX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +8.70% |
| 1 year | +20.29% |
| 3 years (annualised) | +16.30% |
| 5 years (annualised) | +9.77% |
VLCGX Annual Returns
Calendar-year total returns of Large Cap Core Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +8.70% |
| 2025 | +9.83% |
| 2024 | +16.24% |
| 2023 | +23.90% |
| 2022 | −19.17% |
| 2021 | +26.03% |
| 2020 | +22.43% |
| 2019 (Sep–Dec) | +10.41% |
VLCGX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.0% | −1.5% | −5.6% | +10.9% | +4.3% | — | — | — | — | — | — | — |
| 2025 | +2.4% | −1.4% | −6.1% | −1.3% | +6.1% | +3.8% | +2.7% | +0.7% | +1.3% | +1.8% | +0.1% | −0.2% |
| 2024 | +1.1% | +4.6% | +2.2% | −4.5% | +4.9% | +2.3% | +1.3% | +1.9% | +2.4% | −2.7% | +4.5% | −2.3% |
| 2023 | +6.2% | −3.6% | +5.3% | +1.4% | +0.1% | +6.7% | +1.5% | −1.4% | −5.4% | −1.8% | +10.3% | +3.5% |
| 2022 | −5.4% | −4.3% | +2.4% | −7.6% | +0.1% | −6.7% | +8.4% | −4.9% | −10.3% | +6.1% | +8.1% | −4.6% |
| 2021 | −2.3% | +2.7% | +3.1% | +6.7% | −0.4% | +2.3% | +4.5% | +2.3% | −5.6% | +6.8% | −2.0% | +6.2% |
| 2020 | +0.3% | −7.5% | −11.5% | +12.1% | +5.7% | +2.0% | +6.4% | +6.0% | −2.1% | −2.4% | +10.2% | +3.9% |
| 2019 | — | — | — | — | — | — | — | — | +1.1% | +0.7% | +4.8% | +3.5% |
VLCGX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 13.63%
- 3-year Sharpe ratio: 0.87 (vs 4.5% risk-free rate)
- Best month: +10.95% (Apr 2026)
- Worst month: −6.13% (Mar 2025)
VLCGX Fund Flows
Monthly money in and out of Large Cap Core Fund, from SEC Form N-PORT.
- 12-month net flow: $174.6M
- 12-month gross sales (incl. reinvestments): $300.8M
- Sales ÷ redemptions: 2.38×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $72K | $19.3M | −$19.2M |
| Apr 2026 | $3.2M | $8.7M | −$5.5M |
| Mar 2026 | $74.5M | $15.1M | $59.4M |
| Feb 2026 | $2.4M | $11.2M | −$8.8M |
| Jan 2026 | $155K | $13.0M | −$12.9M |
| Dec 2025 | $3.4M | $15.0M | −$11.6M |
| Nov 2025 | $216.0M | $6.3M | $209.7M |
| Oct 2025 | $220K | $8.8M | −$8.6M |
| Sep 2025 | $248K | $6.3M | −$6.1M |
| Aug 2025 | $34K | $1.5M | −$1.5M |
| May 2025 | $225K | $10.2M | −$10.0M |
| Apr 2025 | $366K | $10.6M | −$10.3M |
VLCGX Assets Under Management
Net assets of Large Cap Core Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $819.17M |
| 2026-02-28 | $788.75M |
| 2025-11-30 | $827.16M |
| 2025-08-31 | $608.97M |
| 2025-05-31 | $587.79M |
| 2025-02-28 | $629.68M |
| 2024-11-30 | $654.95M |
| 2024-08-31 | $651.72M |
| 2024-05-31 | $630.29M |
| 2024-02-29 | $684.23M |
| 2023-11-30 | $683.35M |
| 2023-08-31 | $677.86M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.